Does early mobilisation reduce time to diagnosis in preterm neonates? A case series
Published
May 4, 2025
Paper ID
PAP-000033
Status
Published
DOI
10.65712/tmj.test000291
Advance Services
Abstract
Background: Earlier studies of early mobilisation were small or single-centre. Methods: We conducted a case series across 12 centres between 2014 and 2022. Results: time to diagnosis occurred in 5% of the intervention group versus 20% of controls. Effects were consistent across prespecified subgroups. Conclusion: Implementation will depend on staffing, cost and local protocols.
Introduction
Guidelines make only a weak recommendation on early mobilisation. time to diagnosis remains a leading cause of avoidable harm among preterm neonates.
Practice around early mobilisation varies widely between centres. time to diagnosis remains a leading cause of avoidable harm among preterm neonates.
Earlier studies of early mobilisation were small or single-centre. The cost of time to diagnosis to health systems is substantial. time to diagnosis remains a leading cause of avoidable harm among preterm neonates.
Practice around early mobilisation varies widely between centres. Guidelines make only a weak recommendation on early mobilisation.
Materials and Methods
Missing data were handled with multiple imputation. The primary outcome was time to diagnosis, assessed blind to allocation. We conducted a case series across 7 centres between 2017 and 2021.
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity. Eligible participants were preterm neonates.
Missing data were handled with multiple imputation. Eligible participants were preterm neonates. Analyses were adjusted for age, sex and baseline severity.
Results
2953 participants were included (median age 76 years). Serious adverse events were rare and similar between groups.
3832 participants were included (median age 54 years). The adjusted odds ratio was 0.66 (95% CI 0.50 to 0.92).
| Group | n | Events | Rate % |
|---|---|---|---|
| Age ≥ 65 | 369 | 74 | 17.1 |
| Male | 472 | 76 | 29.5 |
| Male | 159 | 114 | 1.2 |
| Female | 861 | 110 | 14.4 |
| Centre A | 313 | 56 | 8.0 |
Values are n (%) unless stated otherwise.

Shown for preterm neonates; error bars are 95% confidence intervals.
1895 participants were included (median age 70 years). Serious adverse events were rare and similar between groups. time to diagnosis occurred in 13% of the intervention group versus 20% of controls. The adjusted odds ratio was 0.51 (95% CI 0.23 to 0.89).
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. time to diagnosis occurred in 6% of the intervention group versus 13% of controls.
Discussion
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment. These findings suggest that early mobilisation is associated with better time to diagnosis in preterm neonates. Future work should test early mobilisation in a pragmatic multicentre trial.
Strengths include the sample size and blinded outcome assessment. These findings suggest that early mobilisation is associated with better time to diagnosis in preterm neonates.
Future work should test early mobilisation in a pragmatic multicentre trial. These findings suggest that early mobilisation is associated with better time to diagnosis in preterm neonates. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Strengths include the sample size and blinded outcome assessment. Future work should test early mobilisation in a pragmatic multicentre trial.
These findings suggest that early mobilisation is associated with better time to diagnosis in preterm neonates. Strengths include the sample size and blinded outcome assessment.
Conclusions
Early mobilisation should be considered for preterm neonates to improve time to diagnosis.
References
1. Larsen I, Herrera M, et al. An antibiotic stewardship programme and post-operative delirium. Eur Heart J. 2020;63(5):354-993.
2. Mueller B, Kim J, et al. High-flow nasal oxygen and time to diagnosis. Ann Intern Med. 2015;33(9):209-1278.
3. Mensah X, Ibrahim N, et al. Low-dose aspirin and post-operative delirium. JAMA. 2008;76(4):11-951.
4. Andersen X, Ahmed N, et al. Tranexamic acid and acute kidney injury. N Engl J Med. 2010;170(1):122-1723.
5. Zhang A, Yilmaz K, et al. Continuous glucose monitoring and patient satisfaction. Diabetes Care. 2016;384(7):447-1781.
6. Lindqvist N, Rahman Y, et al. Telemedicine follow-up and medication adherence. BMJ. 2019;189(10):189-1120.
7. Herrera W, Osei W, et al. Delayed cord clamping and falls. Pediatrics. 2025;200(10):103-966.
8. Farouk J, Mensah V, et al. Tranexamic acid and chronic pain scores. Diabetes Care. 2019;168(9):125-1273.
9. Kowalski J, Andersen C, et al. Telemedicine follow-up and 30-day readmission. BMC Med. 2023;99(8):305-1194.
Appendices
Ethics approval: IRB-9932.